Publications

Found 83 results
Author Title Type [ Year(Desc)]
2021
Vatter FAPelissie, Cioffi M, Hanna SJ, Castarede I, Caielli S, Pascual V, Matei I, Lyden D.  2021.  Extracellular vesicle- and particle-mediated communication shapes innate and adaptive immune responses.. J Exp Med. 218(8)
Alonso L, Méndez-Echevarría A, Rudilla F, Mozo Y, Soler-Palacin P, Sisinni L, Bueno D, Riviere J, de Paz R, Sánchez-Zapardiel E et al..  2021.  Failure of Viral-Specific T Cells Administered in Pre-transplant Settings in Children with Inborn Errors of Immunity.. J Clin Immunol. 41(4):748-755.
Ahmed W, Lukin DJ.  2021.  Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance. Inflamm Bowel Dis. 27(6):787-790.
Doron I, Leonardi I, Li XV, Fiers WD, Semon A, Bialt-DeCelie M, Migaud M, Gao IH, Lin W-Y, Kusakabe T et al..  2021.  Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies.. Cell. 184(4):1017-1031.e14.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y et al..  2021.  Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance.. medRxiv.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V et al..  2021.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.. Cell Metab. 33(11):2174-2188.e5.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V et al..  2021.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.. Cell Metab. 33(12):2484.
Teng F, Tachó-Piñot R, Sung B, Farber DL, Worgall S, Hammad H, Lambrecht BN, Hepworth MR, Sonnenberg GF.  2021.  ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.. Cell Rep. 37(8):110051.
Guo C-J.  2021.  Immune activation kickstarts the gut microbiota.. Cell Host Microbe. 29(3):318-320.
Amir M, Zeng MY.  2021.  Immune imprinting in utero.. Science. 373(6558):967-968.
Charilaou P, Tricarico C, Battat R, Scherl EJ, Longman RS, Lukin DJ.  2021.  Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination.. Clin Gastroenterol Hepatol.
Charbord J, Ren L, Sharma RB, Johansson A, Ågren R, Chu L, Tworus D, Schulz N, Charbord P, Stewart AF et al..  2021.  In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR.. Nat Metab. 3(5):682-700.
Tchang BG, Askin G, Sahagun A, Hwang J, Huang H, Curanaj FAMendelso, Seley JJ, Safford MM, Alonso LC, Aronne LJ et al..  2021.  The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.. Obesity (Silver Spring). 29(6):971-975.
Winkler A, Sun W, De S, Jiao A, M Sharif N, Symanowicz PT, Athale S, Shin JH, Wang J, Jacobson BA et al..  2021.  The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.. Arthritis Rheumatol. 73(12):2206-2218.
Ma C, Sedano R, Almradi A, Casteele NVande, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R et al..  2021.  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.. Gastroenterology. 160(7):2291-2302.
Chung H, Parkhurst CN, Magee EM, Phillips D, Habibi E, Chen F, Yeung BZ, Waldman J, Artis D, Regev A.  2021.  Joint single-cell measurements of nuclear proteins and RNA in vivo.. Nat Methods. 18(10):1204-1212.
Sharma RB, Landa-Galván HV, Alonso LC.  2021.  Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells.. Diabetes. 70(11):2431-2443.
Doron I, Mesko M, Li XV, Kusakabe T, Leonardi I, Shaw DG, Fiers WD, Lin W-Y, Bialt-DeCelie M, Román E et al..  2021.  Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn's disease.. Nat Microbiol. 6(12):1493-1504.
Zhang G, Alshreimi AS, Alonso L, Antar A, Yu H-C, Islam SM, Anderson LL.  2021.  Nitrone and Alkyne Cascade Reactions for Regio- and Diastereoselective 1-Pyrroline Synthesis.. Angew Chem Int Ed Engl. 60(23):13089-13097.
Lukin DJ, Funez-dePagnier G, Lima S, Lai D, Duenas-Bianchi L, Ahmed W, Jacob V, Battat R, Scherl E, Longman RS.  2021.  No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.. Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
Shukla AP, Tchang BG, Lam T, Steller I, Touhamy S, Askin G, Curanaj FAMendelso, Seley JJ, Lorber D, Safford MM et al..  2021.  Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.. J Diabetes Complications. 35(8):107967.
Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF et al..  2021.  A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.. Gastroenterology. 161(3):837-852.e9.
Kumar A, Magro C, Lukin DJ.  2021.  Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.. Gastroenterology. 160(3):e3-e5.
Lawlor N, Nehar-Belaid D, Grassmann JDS, Stoeckius M, Smibert P, Stitzel ML, Pascual V, Banchereau J, Williams A, Ucar D.  2021.  Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS or Anti-CD3 and Anti-CD28.. Front Immunol. 12:636720.
Ahmed W, Lukin DJ.  2021.  A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease.. Lancet Gastroenterol Hepatol. 6(12):973-975.